Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Mirvetuximab soravtansine (ADC) (DHD10499)

Applications:Research Grade Biosimilar
Overview

Catalog No.

DHD10499

Description

Mirvetuximab soravtansine is an ADC consisting of an FRA-directed antibody and DM4 used for the study of ovarian cancer and other FRα-positive cancers.

Species reactivity

Human

Clonality

Monoclonal

Target

FRA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Purification

Purified by Ion Exchange Chromatography.

Applications

Research Grade Biosimilar

Form

Liquid

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

ELAHERE, huFR107-SPDB-DM4

Clone ID

Mirvetuximab soravtansine

Data Image
References
Datasheet
$ 2540
Product specifications
1 mg 2540 5 mg 6360

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Mirvetuximab soravtansine (ADC) [DHD10499]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only